Literature DB >> 5077517

The fate of ( 14 C)carbenoxolone in patients with gastric ulcer.

D V Parke, T C Hunt, P Iveson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5077517     DOI： 10.1042/cs0430393

Source DB:  PubMed          Journal:  Clin Sci        ISSN： 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  3 in total

1.  Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects.

Authors:  M J Hayes; M Sprackling; M J Langman
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

Review 2.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects.

Authors:  J H Baron; J N Gribble; C Rhodes; P A Wright
Journal:  Gut       Date:  1978-04       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.